Published: Feb, 2018

With the presence of several large players, the vendor landscape of the global viral inactivation market is a fragmented one, says Transparency Market Research in a new report. Despite this scenario, a large percentage of market share is held by a few large players that hold prominence. These players are striving for research and development of newer viral inactivation processes that can help them gain competitive advantage. Expansion into regional markets by means of associations with local players is also on the cards of large companies in the viral inactivation market.

Some key players in the global viral inactivation market are Thermo Fisher Scientific Inc., Merck & Co. Inc., Cerus Corporation, Terumo BCT Inc., Sartorius AG, V.I.P.S. SA, Shandong Weigao Group Medical Polymer Company Limited, and Macopharma SA.

According to the TMR report, the global viral inactivation market was valued at US$3.05 bn in 2016. The market is likely to attract a revenue of US$5.736 bn by the end of 2025 rising at a CAGR of 7.4% between 2017 and 2025. Among the various types of method, chemical method dominates the market with maximum market share due to its efficacy for inactivation of different types of viruses. Attributes of safe, cost-effective, and efficacy for high degree of purity of sample also stoke demand for chemical method. The radiation method, on the other hand, is likely to outpace other methods in terms of growth rate over the forecast period. Geography-wise, North America currently holds sway over other segments due to a robust biopharmaceutical industry and early adoption of newer viral inactivation methodologies.

global viral inactivation market revenueProliferation of Biologics Industry Serves to Push Market

At the forefront of driving the global viral inactivation market is rising approvals of new drugs, rules in place that monitor viral safety of biologics, and expansion of the biologics and biosimilars industry. These factors provide much of the impetus needed for the growth of viral inactivation market.

The soaring demand for biosimilars in developed as well as developing countries on the backdrop of rising need for cost effective generics as an alternative to high-cost biologics brand is also serving to boost the viral inactivation market. As a matter of fact, biopharmaceutical products that are of high value are likely to witness patent expiration in the near future thereby providing a major push to the growth of the said market.

Moreover, rising incidence of contagious diseases along with widespread adoption of biosimilars therapeutic treatment for a myriad disease indication are also anticipated to act as a positive influencer for the growth of the said market.

High Cost of Manufacture of Biologics Mar Growth

However, several factors mar the progress of the viral inactivation market. High cost associated with the manufacture of biologics and biosimilars is acting as a restraint to the growth of this market. The equipment involved with viral inactivation is also pricey and thus restrain the market’s growth.

Nevertheless, efforts for the development of novel vaccines due to the emergence of many new viruses is likely to offer new growth opportunities for the viral inactivation market.

The review presented here is based on the findings of a TMR report, titled “Viral Inactivation Market (Method – Chemical and Radiation; Application – Blood and Blood Products, Vaccines, and Cell and Tissue Culture; End-user - Pharmaceutical and Biotechnology Companies, Blood Banks and Hospitals, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.

Key Takeaways

  • Rising Demand for cost-effective generics in place of branded drugs serves to push market
  • Widespread adoption of biosimilars for treatment of a host of contagious diseases boosts growth

The global viral inactivation market is segmented as follows:

Global Viral inactivation Market: By Method

  • Chemical Method
  • Radiation Method
  • Other Methods

Global Viral inactivation Market: By Application

  • Blood & Blood Products
  • Vaccines
  • Cell & Tissue Culture

Global Viral inactivation Market: By End-User

  • Pharmaceutical & Biotechnology Companies
  • Blood Banks & Hospitals
  • Contract Research Organizations
  • Other

Global Viral inactivation Market: By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Middle East Africa (MEA)
    • Middle East
    • Africa

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com